Factor IX - China Biologic Products

Drug Profile

Factor IX - China Biologic Products

Alternative Names: Human coagulation factor IX - China Biologic Products

Latest Information Update: 22 Sep 2016

Price : $50

At a glance

  • Originator China Biologic Products
  • Class Antihaemorrhagics; Blood coagulation factors
  • Mechanism of Action Blood coagulation factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Haemophilia B

Most Recent Events

  • 19 Sep 2016 China Biologic Products plans a clinical trial for Haemophilia B in China
  • 25 Feb 2016 Preclinical trials in Haemophilia B in China (Parenteral)
  • 25 Feb 2016 China Biologic Products submits Paediatric clinical trial application to the CFDA for Haemophilia B (China Biologic Products, Form 10-K, February 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top